The first federal Vioxx case has begun—again. After the previous case ended in a mistrial, plaintiff attorneys hope to convince the jury that Vioxx caused the 2001 deadly heart attack of Richard “Dicky” Irvin.
According to plaintiff attorneys acting on behalf of Mr. Irvin’s family, Merck knew that Vioxx had the potential to cause cardiovascular events, but hastily marketed the drug to gain profits. The attorneys also have learned since the last trial that Merck did not completely disclose all heart attack data in their study published in the New England Journal of Medicine.
Plaintiff attorneys are prepared this time to prove that Merck lied to the medical community along with deceiving the patients taking the drug to relieve pain.
For more information about Vioxx, visit our Vioxx Legal Center.